BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta. The research teams of associate professor Cecilia Götherström and professor Magnus Westgren have shown that that treatment with BOOST Cells greatly enhanced the quality of life for patients suffering from this otherwise extremely debilitating disease.
| Website | https://www.boostpharma.dk/ |
| Employees | 17 (6 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Cell Therapy Research, Regenerative Medicine, Drug Development, Pharmaceutical Research, Biotechnology, Biopharmaceutical, Innovative Treatments, Rare Disease Treatment, Clinical Trials, Breakthrough Therapies, Therapeutics, Advanced Therapies, Medical Research, Health Technology, Pharmaceutical |
| Competitors | Roche, Novartis, Pfizer, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Biogen, Lilly India +39 more (view full list) |
Looking for a particular BOOST Pharma employee's phone or email?
BOOST Pharma Questions
Hans Schambye is the CEO of BOOST Pharma.
6 people are employed at BOOST Pharma.
Top BOOST Pharma Employees
-
Hans Schambye
Chief Executive Officer at BOOST Pharma
Copenhagen, DK34 -
Louise Himmelstrup
Chief Regulatory Officer at BOOST Pharma
Copenhagen, DK1 -
Anthony Hall
Chief Medical Officer at BOOST Pharma
United Kingdom23 -
Lilian Jallow
Chief Development Officer (CDO) and co-founder at BOOST Pharma
Stockholm County, Sweden2 -
32
-
Anne Knap
Project Coordinator at BOOST Pharma
Copenhagen, DK2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
